Spark Therapeutics Announces Collaboration with Leading Gene Therapy Center at University of Massachusetts Medical School
/
Date20 Oct 2016
PHILADELPHIA, Oct. 20, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating... Read More →
Strong finish of the financial year
/
Date20 Oct 2016
Fourth quarter · Net sales for the quarter rose 11.0 per cent to SEK 1,952 million (1,759). · Organic growth in fixed exchange rates was... Read More →
Stark avslutning på verksamhetsåret
/
Date20 Oct 2016
Fjärde kvartalet · Nettoomsättningen ökade med 11,0 procent under kvartalet till 1 952 miljoner kronor (1 759). · Den organiska tillväxten i fasta växelkurser var... Read More →
RadioMedix Inc. successfully completed the Phase I/ II clinical studies for AminoMedix ™ used for radiation kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT)
/
Date20 Oct 2016
Houston, TX, Oct. 20, 2016 (GLOBE NEWSWIRE) — RadioMedix Inc. (Houston,TX) is excited to announce the completion of the Phase I/II clinical trial of AminoMedix... Read More →
ABLYNX OUTLINES NEXT STEPS FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, A POTENTIAL BEST-IN-CLASS TREATMENT FOR RHEUMATOID ARTHRITIS
/
Date20 Oct 2016
AbbVie has decided at this time not to exercise its right to opt-in and license vobarilizumab in RA Additional analysis of the Phase IIb RA... Read More →
iRhythm Technologies Announces Pricing of Initial Public Offering
/
Date20 Oct 2016
SAN FRANCISCO, Oct. 19, 2016 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc., a leading digital health care solutions company focused on the advancement of cardiac care, today... Read More →
BioMarin Presents Vosoritide Data in Achondroplasia at American Society of Human Genetics (ASHG) 2016 Meeting
/
Date19 Oct 2016
Highest Dose (30 µg/kg/day) Shows Approximately 50% Increase in Mean Annualized Growth Velocity, Comparable with 15 µg/kg/day dose Consistent Safety Profile at High Dose Findings Support... Read More →
AGTC Files Investigational New Drug Application for the Treatment of Achromatopsia Caused by Mutations in the CNGA3 Gene
/
Date19 Oct 2016
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 19, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated... Read More →
Avinger Announces Expanded FDA Indications for Pantheris™ as Diagnostic Imaging Device
/
Date19 Oct 2016
REDWOOD CITY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced... Read More →
Machine Vision Camera Market to Elevate Beyond $2 Billion by 2021
/
Date19 Oct 2016
Hyderabad, Oct. 19, 2016 (GLOBE NEWSWIRE) — According to the new report “Global Machine Vision Camera Market Analysis and Forecast (2016-2021): By Types (Vision Sensors,... Read More →